메뉴 건너뛰기




Volumn 52, Issue 2, 2011, Pages 311-317

Variations in PET/CT methodology for oncologic imaging at U.S. academic medical centers: An imaging response assessment team survey

Author keywords

IRAT; Oncology; PET CT; PET CT; Quality assurance; Standardization; Variation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

EID: 79851471019     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.074104     Document Type: Article
Times cited : (85)

References (9)
  • 1
    • 69149109735 scopus 로고    scopus 로고
    • Positron emission tomography in staging early lung cancer: A randomized trial
    • Maziak DE, Darling GE, Inculet RI, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med. 2009;151:221-228.
    • (2009) Ann Intern Med , vol.151 , pp. 221-228
    • Maziak, D.E.1    Darling, G.E.2    Inculet, R.I.3
  • 2
    • 67649660400 scopus 로고    scopus 로고
    • Preoperative staging of lung cancer with combined PET-CT
    • Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med. 2009;361:32-39.
    • (2009) N Engl J Med , vol.361 , pp. 32-39
    • Fischer, B.1    Lassen, U.2    Mortensen, J.3
  • 3
    • 0037140187 scopus 로고    scopus 로고
    • Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-smallcell lung cancer: The PLUS multicentre randomised trial
    • van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-smallcell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002;359:1388-1393.
    • (2002) Lancet , vol.359 , pp. 1388-1393
    • Van Tinteren, H.1    Hoekstra, O.S.2    Smit, E.F.3
  • 4
    • 33746036112 scopus 로고    scopus 로고
    • 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
    • 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med. 2006;47:1059-1066.
    • (2006) J Nucl Med , vol.47 , pp. 1059-1066
    • Shankar, L.K.1    Hoffman, J.M.2    Bacharach, S.3
  • 5
    • 58149307938 scopus 로고    scopus 로고
    • The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
    • Boellaard R, Oyen WJ, Hoekstra CJ, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging. 2008;35:2320-2333.
    • (2008) Eur J Nucl Med Mol Imaging , vol.35 , pp. 2320-2333
    • Boellaard, R.1    Oyen, W.J.2    Hoekstra, C.J.3
  • 6
    • 72949107608 scopus 로고    scopus 로고
    • FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: Version 1.0
    • Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181-200.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , pp. 181-200
    • Boellaard, R.1    O'Doherty, M.J.2    Weber, W.A.3
  • 7
    • 79851496936 scopus 로고    scopus 로고
    • Web site. Available at: Accessed September 3, 2010
    • ACRIN PET Core Laboratory Standard Operating Procedures. American College of Radiology Imaging Network Web site. Available at: www.acrin.org/CORELABS/ PETCORELABORATORY/PETSOPS/tabid/484/Default.aspx. Accessed September 3, 2010.
    • ACRIN PET Core Laboratory Standard Operating Procedures
  • 8
    • 36549007486 scopus 로고    scopus 로고
    • Computed tomography - An increasing source of radiation exposure
    • DOI 10.1056/NEJMra072149
    • Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-2284. (Pubitemid 350190758)
    • (2007) New England Journal of Medicine , vol.357 , Issue.22 , pp. 2277-2284
    • Brenner, D.J.1    Hall, E.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.